Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Cheeseman

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062)K H Moore, R H Raasch, K L Brouwer, et al.
Transplantation Proceedings|March 1, 1979
Cytomegalovirus excretion 2-14 years after renal transplantationS H Cheeseman, J A Stewart, S Winkle, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonatesD R Snydman, B G Werner, H C Meissner, et al.
The New England Journal of Medicine|November 29, 1984
Virologic studies in a case of transfusion-associated AIDSJ E Groopman, S Z Salahuddin, M G Sarngadharan, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Pharmacokinetics of nevirapine: initial single-rising-dose study in humansS H Cheeseman, S E Hattox, M M McLaughlin, et al.
The Journal of Infectious Diseases|May 1, 1985
Cytomegaloviral infection and diseaseJ S Kinney, I M Onorato, J A Stewart, et al.
The Journal of Pediatrics|April 1, 1986
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesvirusesJ L Sullivan, F E Brewster, D B Brettler, et al.
Annals of Internal Medicine|July 1, 1980
Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferonS H Cheeseman, W Henle, R H Rubin, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062)K H Moore, R H Raasch, K L Brouwer, et al.
Transplantation Proceedings|March 1, 1979
Cytomegalovirus excretion 2-14 years after renal transplantationS H Cheeseman, J A Stewart, S Winkle, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonatesD R Snydman, B G Werner, H C Meissner, et al.
The New England Journal of Medicine|November 29, 1984
Virologic studies in a case of transfusion-associated AIDSJ E Groopman, S Z Salahuddin, M G Sarngadharan, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Pharmacokinetics of nevirapine: initial single-rising-dose study in humansS H Cheeseman, S E Hattox, M M McLaughlin, et al.
The Journal of Infectious Diseases|May 1, 1985
Cytomegaloviral infection and diseaseJ S Kinney, I M Onorato, J A Stewart, et al.
The Journal of Pediatrics|April 1, 1986
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesvirusesJ L Sullivan, F E Brewster, D B Brettler, et al.
Annals of Internal Medicine|July 1, 1980
Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferonS H Cheeseman, W Henle, R H Rubin, et al.
Pageof 4